Keywords: roche, obesity, drug, xenical, gains, approval, earlier

Roche's obesity drug Xenical gains US approval earlier than forecast

Article | 27 April 1999

Print This

Roche's eagerly-anticipated weight loss drug Xenical (orlistat) has beenapproved in the USA, the largest market for this type of drug, ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in